Recent Headlines
Within Pharmaceuticals
AnaSpec Introduces Fourteen New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced fourteen (14) new peptides for drug discovery research. HIV Nef (68–76) - Cat# 61673 This HIV nef peptide 68 to 76 amino acids was identified in HIV-infected individuals. It is a B7... - July 27, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 12 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added twelve (12) new antibodies to its growing collection of catalog antibodies. The targeted research area for these antibodies is signal transduction and matrix... - July 26, 2007 - AnaSpec, EGT Group
Dry Skin, Cracked Heels, Calluses and Corns Become More Noticeable and Painful During the Summer Months; the Personal Pumi Bar from Teregen Provides Relief
The Personal Pumi Bar gently removes dry Skin, cracked heels, calluses and corns that develop and worsen on feet during the summer months. - July 26, 2007 - Teregen Personal Products
AnaSpec Introduces Ten New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new peptides for drug discovery research. MUC4 - Cat# 61339 This peptide is derived from the tandem repeat of Muc 4 mucin protein. Mucins are highly O-glycosylated proteins which... - July 25, 2007 - AnaSpec, EGT Group
Xcelience Expanding Operations
The Tampa-based contract research organization acquires a brand new building. - July 23, 2007 - Xcelience, LLC
Local Merger Creates Advanced Orthopedics and Sports Medicine Institute
Western Monmouth Orthopedic Associates and New Jersey Orthopedic Associates have merged to form Advanced Orthopedics and Sports Medicine Institute, PC (AOSMI). The seven practicing physicians have a combined 100 years of experience practicing medicine, and are all committed to providing Patient-Centered, Patient-Focused care, positioning AOSMI as a leading provider of orthopedic health care in Central New Jersey and the Monmouth County, NJ area. - July 23, 2007 - Advanced Orthopedics and Sports Medicine Institute, PC
AnaSpec Introduces Eleven New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eleven (11) new peptides for drug discovery research. - July 22, 2007 - AnaSpec, EGT Group
Supplement Marketer Signs Agreement with Amazon.com, Inc.
Parason Health Products, Inc., makers of ISNA Halal certified dietary supplements, signs agreement with Fortune 500 online e-commerce retailer Amazon.com to sell Parason® brand products. - July 20, 2007 - Parason Health Products, Inc.
AnaSpec Introduces New Selection of Cathelicidin Peptides
Cathelicidins are cationic peptides that have broad-range antimicrobial activity. These peptides belong to the family of anti-microbial peptides which form part of the host’s important innate immunity mechanism. - July 20, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Anti-MMP-1 & Anti-MMP-13 (Hinge) Antibodies
AnaSpec has introduced its newest antibody solutions – anti-MMP-1 (Hinge) and anti-MMP-13 (Hinge) antibodies. Strategically raised against the hinge regions of MMP-1 and MMP-13, the epitopes do not overlap the catalytic domain and will not influence the activity of the MMP ferment in... - July 19, 2007 - AnaSpec, EGT Group
Gamma Medica-Ideas Announces Sale of Flex TriumphTM Multi-Modality Pre-Clinical Imaging System to Université de Rouen
Gamma Medica-Ideas Inc. (GM-I), a leader in providing next-generation medical imaging devices for the pre-clinical and clinical markets, announced today that Université de Rouen in France has placed an order for a dual-modality Flex TriumphTM pre-clinical platform – including its... - July 19, 2007 - Gamma Medica-Ideas
“Premix vs. Custom TPN” Technical Paper Sponsored by Baxa Corporation Now Posted on Expert411.com for Media Access
The “Premix vs. Custom TPN” technical paper, sponsored by Baxa Corporation, is now available at Expert411.com for media and professional access. The paper, which provides a history of nutritional best practice and an examination of the use of premixed solutions for parenteral nutrition, is authored by Louis S. Diorio, RPh, and David L. Thomas, RPh MBA, both with Certified Consultant Pharmacists Healthcare Associates , Inc of Chatham, NJ. - July 18, 2007 - Baxa Corporation
Baxa Corporation Named One of Best Companies to Work for in Colorado
For the second year in a row, Englewood-based Baxa Corporation has been selected as one of Colorado’s best companies to work for; based on results from employee surveys by the Society for Human Resource Management (SHRM). Best Company finalists promote the best employment opportunities in the state – attracting new workers and promoting their retention. - July 16, 2007 - Baxa Corporation
CureHIV Predicts Number of HIV Cases to Skyrocket
Dr. Hershline states that, baring a new preventative, CureHIV now predicts over 700 million worldwide HIV infected humans by the New Year 2018, as this global pandemic emerges. - July 15, 2007 - CureHIV
American Peptide Symposium Poster Describes Synthesis of Hydrocarbon-Stapled Peptides
At the 2007 annual conference of the American Peptide Society, AnaSpec presented a technical poster that described the facile synthesis of a hydrocarbon-stapled peptide. Asymmetric synthesis of (S)-Fmoc-α-(2’-pentenyl)-alanine was successfully accomplished via an Ala-Ni (II)-BPB-complex... - July 14, 2007 - AnaSpec, EGT Group
AnaSpec Presents Late-Breaking In Vivo Imaging Poster at American Peptide Symposium
At the 2007 annual conference of the American Peptide Society, AnaSpec presented a “late-breaking” technical poster that described in vivo imaging using a tissue-specific near infrared fluorescent peptide conjugate. Extracellular matrix proteins that contain the Arg-Gly-Asp (RGD)... - July 13, 2007 - AnaSpec, EGT Group
Cornerstone BioPharma, Inc. and SJ Pharmaceuticals, LLC Sign Co-Promotion Agreement
Cornerstone BioPharma™, the Triangle-based specialty pharmaceutical company currently focused on the development and commercialization of niche prescription medications in the respiratory arena, today announced it has signed a co-promotion agreement with SJ Pharmaceuticals (SJP). This... - July 12, 2007 - Cornerstone BioPharma
Advanced Orthopedics and Sports Medicine Institute Revolutionizes Knee Replacement Procedures for Women
The orthopedic surgeons at the Advanced Orthopedics and Sports Medicine Institute, PC (AOSMI) are among the first surgeons in the Freehold, New Jersey area to offer the Zimmer® Gender Solutions™ Knee, which is the first and only knee replacement shaped to fit a woman’s anatomy. - July 11, 2007 - Advanced Orthopedics and Sports Medicine Institute, PC
Dr. Nasar Appointed Medical Director of CentraState Total Joint Center
Dr. Alan Nasar, a leading orthopedic surgeon at the Advanced Orthopedics and Sports Medicine Institute, PC (AOSMI), is the newly appointed medical director of the Total Joint Center of New Jersey. He draws from his training and experience in orthopedic care and mechanical engineering to offer his patients a variety of joint replacement options that are designed for faster recovery and better outcomes. - July 11, 2007 - Advanced Orthopedics and Sports Medicine Institute, PC
Magellan BioScience Group, Inc. Awarded SBIR Grant for anti-Malarial Drug Discovery Collaboration with University of South Florida
Magellan BioScience Group, Inc. (Magellan), a pioneer in innovative drug discovery and development from marine microbial sources, and the University of South Florida (USF) announced today that they have been awarded a Phase I Small Business Innovative Research Grant (SBIR) from the National... - July 06, 2007 - CoreRx, Inc.
Second Annual “XanGo Cup” to Feature Pioneer Holiday RSL Friendlies with Elite Clubs Everton and Boca Juniors
Events Include Official Opening of RSL’s New XanGo Campus Practice Field - June 29, 2007 - XanGo, LLC
Baxa Corporation Features Pharmacy Training Programs, Abacus™ Software and ValiMed™ Medication Validation System at the ASHP Summer Meeting
Baxa Corporation is promoting its industry-leading STAR Center pharmacy training facility, CriticalPoint™ online sterile compounding certification training, Abacus TPN ordering and calculation software and the ValiMed System for medication validation at the American Society of Health-System Pharmacists 2007 Summer Meeting and Exhibition beginning today at the Moscone Center in San Francisco. - June 25, 2007 - Baxa Corporation
PharmaChem Publishes AnaSpec Article on Peptides as Antigens
The June issue of PharmaChem, an Italian journal covering the drug discovery industry, featured an article written by AnaSpec called “Peptides as Antigens.” The technical article, written by Dr. Daniel Li and Cecilia Po, outlines the advantages and methodologies behind using peptides as... - June 24, 2007 - AnaSpec, EGT Group
Gamma Medica-Ideas Announces First Sale of a Dual-Head LumaGEM® Molecular Breast Imaging System
Gamma Medica-Ideas Inc. (GM-I), a leader in providing next-generation medical imaging devices for the pre-clinical and clinical markets, announced today the sale of a dual-headed LumaGEM® system for applications such as Molecular Breast Imaging (MBI). This dual head system is the first of its... - June 22, 2007 - Gamma Medica-Ideas
AnaSpec Introduces New SensoLyte™ Beta-Secretase Assay Kit
Leveraging one of the world’s largest collections of amyloid peptides, AnaSpec has introduced its latest development in novel solutions for amyloid-related research - the new SensoLyte™ 520 Beta-Secretase Assay Kit. Beta-secretase catalyzes a key step in the production of beta-amyloid... - June 22, 2007 - AnaSpec, EGT Group
MenScience Acne Spot Repair Gives New Meaning to "In Your Face"
For the majority of men, acne flare-ups do not end with the teen years. Whether it’s a lone pimple or a full-on breakout, acne is an irritating condition that plagues men throughout their lives. It’s because of this that MenScience has created a product that targets pimples and... - June 20, 2007 - MenScience Androceuticals
Baxa Corporation and Health Robotics Announce Strategic Alliance to Automate IV Admixture Preparation
Baxa Corporation and Health Robotics announce a strategic alliance to use the Baxa Two-Fer™ Needles with Health Robotics’ CytoCare™ Robot in order to safely and accurately automate the preparation of patient-specific chemotherapy IV admixtures. This alliance combines state-of-the-art technologies to achieve the accuracy and sterility that providers require. The resulting technology is the only totally automated system for handling hazardous IV admixtures available in the market. - June 18, 2007 - Baxa Corporation
University of Kuopio’s A.I. Virtanen Institute Uses Gamma Medica-Ideas’ FLEX Multi-Modality System to Image Baculovirus Biodistribution in Pre-Clinical Subjects
A team of researchers at University of Kuopio’s A.I Virtanen Institute for Molecular Sciences in Finland is conducting studies in non-invasive imaging with Gamma Medica-Ideas’ MicroSPECT/CT system to provide essential information on biodistribution of gene therapy vectors in rats. The... - June 17, 2007 - Gamma Medica-Ideas
Gamma Medica-Ideas Introduces High Resolution CT Subsystem
Gamma Medica-Ideas (GM-I) announced today the addition of a new High Resolution CT subsystem to the company’s FLEX Triumph™ Pre-clinical Imaging Platform that produces striking improvements in CT imaging. The new CT subsystem contains a variable focal spot x-ray source which provides... - June 17, 2007 - Gamma Medica-Ideas
Thrombotargets Corp. and Magellan Bioscience Group, Inc. to Collaborate on Identification of Novel Hits from Both Marine Derivate and Natural Products
Thrombotargets Corporation and Magellan Bioscience Group, Inc. today announced the formation of drug discovery joint venture. Under the terms of this agreement, Magellan Bioscience Group, Inc. will provide to Thrombotargets its compounds and extracts from fermentation broths of marine-isolated... - June 16, 2007 - CoreRx, Inc.
AnaSpec Introduces Industry’s First and Only Anti-MOG ELISA Kits
Drawing on its broad portfolio of MOG (35-55) and other multiple sclerosis (MS) experimental autoimmune encephalomyelitis (EAE)-related peptides, AnaSpec has just released its new line of SensoLyte™ Anti - MOG ELISA Kits - the industry’s first and only anti-MOG ELISA kits. Myelin... - June 16, 2007 - AnaSpec, EGT Group
ValiMed™ Medication Validation System And Related Information From Baxa Corporation Are Now Available At PublicRelationsNewsroom.com
The ValiMed Medication Validation System and related information are now available at PublicRelationsNewsroom.com. The ValiMed System, distributed by Baxa Corporation, offers clinicians a simple and cost-effective tool to ensure medication safety by verifying that medications are correctly compounded. Its patented technology validates compounded doses of high risk medications prior to dispensing. - June 15, 2007 - Baxa Corporation
Baxa Corporation Recognized by Medical Device & Design Industry Magazine for World-Class Quality Team
Baxa Corporation is profiled as one of eight world-class quality and regulatory teams in the June 2007 issue of Medical Device & Diagnostic Industry magazine. The June article was the first time MD&DI recognized the accomplishments of the quality and regulatory teams that ensure medical products are safe and ready for market. - June 13, 2007 - Baxa Corporation
Metamize365 Introduced – Set to Combat the Over-Looked Issue of Metabolic Syndrome
Dr. Steven Lamm announced yesterday the introduction of his new dietary supplement, Metamize 365. The product is aimed to help combat the often-overlooked metabolic syndrome problem in the US. "Over 50% of Americans have a problem with their metabolism. This often leads to diabetes, heart... - June 13, 2007 - Metamize 365
AnaSpec Prepares Technical Poster about Beta-Secretase Assay for Experimental Biology 2007
At the 2007 Experimental Biology conference in Washington, DC, AnaSpec prepared a technical poster entitled, "A Sensitive Fluorimetric Assay for Detection of beta-Secretase Activity Using a Novel FRET Peptide Substrate." The poster documented the following findings: • A highly... - June 08, 2007 - AnaSpec, EGT Group
Clinical Trials in Russia. 1st Quarter 2007 Results
According to Synergy Research Group, a Russia-based CRO, the growth in the number of clinical trials approved by the Russian Federal Agency for Health Care and Social Development (Roszdravnadzor) made up to nearly 40% in the 1st Quarter of 2007 as compared to the same quarter of the previous year. At the same time, the share of clinical studies initiated by Russian manufacturers has increased. - June 06, 2007 - Synergy Research Group
Functional Genetics, Inc. Receives Award to Discover New Opportunities to Combat HIV Infection
Functional Genetics, Inc. Announces a New Award from the National Institute of Allergy and Infectious Diseases to Utilize Its Core Random Homozygous Gene Perturbation and Host-Oriented Therapeutics Technologies to Identify and Validate New Therapeutic Approaches to Combat HIV Infection - June 03, 2007 - Functional Genetics, Inc.
Summer Fun for Dad and Son This Father’s Day, Give a Dad a Gift That Shines
June ushers in Father’s Day and Sun Safety Week, so in honor of both, MenScience is awarding a ‘Dad that Shines the Brightest Award’. The winner will receive the entire MenScience Father’s Day sun care gift set, complete with the TiO2 Sunblock SPF 30, Advanced Lip... - June 01, 2007 - MenScience Androceuticals
Tias Arms Announces 6th Annual Event “Art Party in the Park” to Raise Funds for Orphaned and Abandoned Children Affected by HIV/AIDS in South Africa
Tias Arms announced today that its 6th annual celebration and fundraising event, this year entitled “Art Party in the Park”, will be held on Sunday, June 10th from 12 noon to 5pm at Park Prive in Costa Mesa. As in previous years, this exciting event will include a silent and live... - June 01, 2007 - Tias Arms
The Imminent Change of the Antithrombotics Market
The antithrombotics market with the two blockbusters enoxaparin and prasugrel is challenged by generic products as well as by next generation anticoagulants with oral administration and antithrombotics with an improved risk-benefit ratio - June 01, 2007 - La Merie Business Intelligence
Novel Agent for Reactive Metabolite Detection
Bioactivation of drug candidates resulting in chemically reactive, electrophilic metabolites have always presented a major challenge to pharmaceutical companies. Moreover, the measurement of these metabolites has been hampered by the lack of an effective quantitative method. QA-GSH is a novel new... - May 31, 2007 - AnaSpec, EGT Group
Colorado BioScience Association Applauds Governor Ritter’s Signing of HB 1060 As Critical To Future Growth of The State’s Bioscience Industry
Colorado Governor Bill Ritter signed House Bill 1060 into law Wednesday afternoon, with the bill sponsors present to acknowledge the importance of the legislation to the bioscience industry in Colorado. Rep. Jim Riesberg (D-Weld) and Sen. Brandon Shaffer (D-Longmont) were thanked for their efforts... - May 25, 2007 - Colorado BioScience Association
Xcelience Will Acquire New Technologies to Enhance Drug Development Processes
The Tampa-based Contract Research Organization signed a partnership that will form new opportunities in the pharmaceutical industry. - May 24, 2007 - Xcelience, LLC
Zoft Gum Company Launches New Product to Ease the Pain of Menopause
Zoft Menopause Gum offers relief for menopausal symptoms in a convenient chewing gum product. - May 23, 2007 - Zoft Gum Company
AnaSpec Introduces Line of Insulin Receptor Antibodies
The insulin receptor is a transmembrane receptor that belongs to the tyrosine kinase receptors class. It is a heterotetrameric glycoprotein composed of disulfide-linked subunits in a β-α-α-β configuration. This transmembrane receptor consists of 95kDa β-subunit, a single... - May 23, 2007 - AnaSpec, EGT Group
Baxa Ltd, Subsidiary of Denver-based Baxa Corporation, Announces Direct Sales and Marketing Operations in Switzerland
Baxa Ltd, subsidiary of Denver-based Baxa Corporation, has moved to a direct sales and marketing model for the Swiss market. The company provides systems and devices for simplifying the handling, mixing and administration of fluid medications. Direct operations will provide Baxa Ltd with improved customer access for product development and continuous improvement, while continuing their excellent customer service. - May 21, 2007 - Baxa Corporation
Colorado BioScience Association Names Jack Wheeler Chairperson, Announces 2007 Sponsors and Appoints Eight New Board Members
Jack Wheeler, CEO of MicroPhage, Inc., Longmont, is the new chairperson of the board of directors for the Colorado BioScience Association (CBSA). He was appointed at the association’s 2007 annual meeting April 24th. Wheeler assumes chairperson responsibilities from Ed Wood, ArcScan, Inc. In other action, eight new board members were appointed to three-year terms. - May 18, 2007 - Colorado BioScience Association
Industry’s First West Nile Virus Protease Assay Kits
While West Nile virus (WNV) has had significant outbreaks throughout the world since it was first identified, commercially available assay kits for the detection of WNV protease inhibitors had not been developed until now. With the SensoLyte™ series of WNV Protease Assay Kits AnaSpec, a... - May 17, 2007 - AnaSpec, EGT Group
Baxa Corporation Wins BMA Colorado 2007 Gold Key Award
Baxa Corporation's direct marketing campaign for the Rapid-Fill™ Automated Syringe Filler was awarded a Business Marketing Association Gold Key in the Colorado Chapter’s 2007 competition. Three messages: Safety is Automatic, Technology that Fits and Designed for Speed emphasized the key attributes that differentiate the Baxa product from competitive products and processes. - May 16, 2007 - Baxa Corporation
Clinical Trials in Russia - First Issue of SynRG Orange Paper
On April 25, 2007, the first issue of the Orange Paper – the first analytical review on market of clinical trials in Russia – was officially presented. The strategic goals of Synergy Research Group, a Russia-based emerging CRO, are formation of a civilized market of clinical trials in... - May 16, 2007 - Synergy Research Group